Eli Lilly (United States)

21.3k papers and 906.8k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (United States) have published 21.3k papers, which have received a total of 906.8k indexed citations. Scholars at this organization have produced 5.8k papers in Molecular Biology, 2.6k papers in Oncology and 2.3k papers in Endocrinology, Diabetes and Metabolism on the topics of Diabetes Treatment and Management (1.1k papers), Neuroscience and Neuropharmacology Research (930 papers) and Diabetes Management and Research (913 papers). Their work is cited by papers focused on Molecular Biology (271.5k citations), Physiology (110.9k citations) and Psychiatry and Mental health (104.8k citations). Authors at Eli Lilly (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Eli Lilly (United States)'s most productive authors include Mark L. Heiman, Ray W. Fuller, Frank P. Bymaster, Darryle D. Schoepp, Steven Wrighton, Matthias H. Tschöp, Lian Yu, Alan Y. Chiang, Donald R. Gehlert and Alexei Kharitonenkov.

In The Last Decade

Fields of papers published by authors at Eli Lilly (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Eli Lilly (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Eli Lilly (United States) at the time of their publication.

Countries citing scholars working at Eli Lilly (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Helmholtz Centre for Infection Research Breakdown of academic impact, for scholars at Max Planck Institute for Polymer Research Breakdown of academic impact, for scholars at Institute of Materials Research and Engineering Breakdown of academic impact, for scholars at University of Massachusetts Chan Medical School Breakdown of academic impact, for scholars at GFZ Helmholtz Centre for Geosciences Breakdown of academic impact, for scholars at City College of New York Breakdown of academic impact, for scholars at Université Joseph Fourier Breakdown of academic impact, for scholars at Southern Methodist University
Rankless by CCL
2025